Peripheral Arterial Disease Trial, Recruiting NCT02748226 Sponsor: Yonsei University Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT02748226
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose medical records include a past endovascular procedure (a minimally invasive blood vessel treatment) for symptomatic peripheral artery disease (reduced blood flow in the limbs causing symptoms), performed between January 2006 and the date the trial was approved — this applies to the retrospective (past data) part of the study
  • People aged 20 years or older who are currently receiving or beginning treatment for symptomatic peripheral artery disease — this applies to the prospective (ongoing) part of the study
  • People who have intermittent claudication, meaning leg pain or cramping during activity that goes away with rest (classified as Rutherford category 1 to 3)
  • People who have critical limb ischemia, meaning severely reduced blood flow to a limb causing rest pain, wounds, or tissue damage (classified as Rutherford category 4 to 6)

Who may not be able to join:

  • Women who are pregnant or who could potentially become pregnant
  • People with moderate Alzheimer's disease, a mental health condition, or a neurological condition that would make it difficult to understand the purpose and procedures of the trial (confirm with trial site)
  • People with other serious health conditions that mean their life expectancy is less than one year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02)-2228-8460

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 September 2013
Est. completion
31 July 2032

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Primary patency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov